ACS Medicinal Chemistry Letters

Published by: American Chemical Society  

People

  1. Campos
    Campos
  2. Chandarlapaty
    Chandarlapaty
  3. De Stanchina
    De Stanchina
  4. Li
    Li
  5. Mellinghoff
    Mellinghoff

Groups

  1. GSK Faculty (4)
  2. Sloan Kettering Institute Postdocs (4)
  3. Human Oncology and Pathogenesis Program (2)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  5. Breast Medicine Service (1)
  6. Department of Medicine (1)
  7. Molecular Pharmacology and Chemistry Program Faculty (1)
  8. Population Sciences Research Program (1)
  9. Radiochemistry and Imaging Sciences Service (1)
  10. Radiology, Department of (1)
Search Within
Formats
  1. Journal Article (3)
  2. Research Letter (3)
Groups
  1. GSK Faculty (4)
  2. Sloan Kettering Institute Postdocs (4)
  3. Human Oncology and Pathogenesis Program (2)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  5. Breast Medicine Service (1)
  6. Department of Medicine (1)

More Groups

People
  1. Carl Campos (1)
  2. Elisa De Stanchina (1)
  3. Ingo Mellinghoff (1)
  4. Jerry Chang (1)
  5. Mirkka Sarparanta (1)
  6. Paolo Codega (1)

More People

Years
  1. 2022 (1)
  2. 2020 (2)
  3. 2018 (1)
  4. 2017 (1)
  5. 2016 (1)
Publishers
  1. American Chemical Society (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A chemical strategy toward novel brain-penetrant EZH2 inhibitors
    Research Letter

    Liang, R.; Tomita, D.; Sasaki, Y.; Ginn, J.; Michino, M.; Huggins, D. J.; Baxt, L.; Kargman, S.; Shahid, M.; Aso, K.; more...
    ACS Medicinal Chemistry Letters (2022)

    Fulltext@MSK | Save
  • Brain permeable tafamidis amide analogs for stabilizing TTR and reducing APP cleavage
    Research Letter

    Sinha, A.; Chang, J. C.; Xu, P.; Gindinova, K.; Cho, Y.; Sun, W.; Wu, X.; Li, Y. M.; Greengard, P.; Kelly, J. W.; more...
    ACS Medicinal Chemistry Letters (2020)

    Fulltext@MSK | Save
  • Vorasidenib (AG-881): A first-in-class, brain-penetrant dual inhibitor of mutant IDH1 and 2 for treatment of glioma
    Research Letter

    Konteatis, Z.; Artin, E.; Nicolay, B.; Straley, K.; Padyana, A. K.; Jin, L.; Chen, Y.; Narayaraswamy, R.; Tong, S.; Wang, F.; more...
    ACS Medicinal Chemistry Letters (2020)

    Fulltext@MSK | Save
  • New class of selective estrogen receptor degraders (SERDs): Expanding the toolbox of PROTAC degrons
    Journal Article

    Wang, L.; Guillen, V. S.; Sharma, N.; Flessa, K.; Min, J.; Carlson, K. E.; Toy, W.; Braqi, S.; Katzenellenbogen, B. S.; Katzenellenbogen, J. A.; more...
    ACS Medicinal Chemistry Letters (2018)

    Fulltext@MSK | Save
  • Synthesis of a fluorescently labeled (68)Ga-DOTA-TOC analog for somatostatin receptor targeting
    Journal Article

    Ghosh, S. C.; Hernandez Vargas, S.; Rodriguez, M.; Kossatz, S.; Voss, J.; Carmon, K. S.; Reiner, T.; Schonbrunn, A.; Azhdarinia, A.
    ACS Medicinal Chemistry Letters (2017)

    Fulltext@MSK | Save
  • A new highly reactive and low lipophilicity fluorine-18 labeled tetrazine derivative for pretargeted PET imaging
    Journal Article

    Keinänen, O.; Li, X. G.; Chenna, N. K.; Lumen, D.; Ott, J.; Molthoff, C. F. M.; Sarparanta, M.; Helariutta, K.; Vuorinen, T.; Windhorst, A. D.; more...
    ACS Medicinal Chemistry Letters (2016)

    Fulltext@MSK | Save

    • ACS Medicinal Chemistry Letters – authorized name for:

    Name ISSN / ISBN Publisher
    ACS Medicinal Chemistry Letters 1948-5875 American Chemical Society
    ACS Medicinal Chemistry Letters 19485875 American Chemical Society
    ACS Medicinal Chemistry Letters 19485875 American Chemical Society
    ACS Medicinal Chemistry Letters 1948-5875 Unknown
    Acs Medicinal Chemistry Letters 1948-5875 American Chemical Society
    ACS Medicinal Chemistry Letters 1948-5875 American Chemical Society